MAIN


1996-2019.  All Rights Reserved. Online Journal of Bioinformatics . You may not store these pages in any form except for your own personal use. All other usage or distribution is illegal under international copyright treaties. Permission to use any of these pages in any other way besides the  before mentioned must be gained in writing from the publisher. This article is exclusively copyrighted in its entirety to OJB publications. This article may be copied once but may not be, reproduced or  re-transmitted without the express permission of the editors. This journal satisfies the refereeing requirements (DEST) for the Higher Education Research Data Collection (Australia). Linking: To link to this page or any pages linking to this page you must link directly to this page only here rather than put up your own page.


OJBTM

Online Journal of Bioinformatics

Volume 18(3):86-100, 2017.


In silico drug design for methylene-tetrahydrofolate reductase

 

Gobind Ram.

 

Department of Biotechnology & Bioinformatics, Lyallpur Khalsa College, jalandhar, Punjab, India.

 

ABSTRACT

 

Ram G., In silico drug design for methylene-tetrahydrofolate reductase, Onl J Bioinform., 15 (3): 86-100, 2018. Methylene-tetra-hydrofolate Reductase (MTHFR) is encoded on chromosome 1 location p36.3. Methylation of homocysteine to methionine is catalyzed by MTHFR through reduction of 5, 10- methylene-tetrahydrofolate to 5-methyltetrahydrofolate. Approximately 24 mutations in the MTHFR gene have been identified in persons with homocysteinuria. C677T (rs1801133) and A1298C (rs1801131) single nucleotide polymorphisms with mutations at C677T and A1298C which confer amino acid substitution Ala222Val and Glu429Ala respectively with reduced activity. Polymorphism and mild hyper-homocysteinemia are associated with neural tube defects in offspring, arterial/venous thrombosis and cardiovascular disease. MTHFR gene may be a risk factor for schizophrenia. In silico analysis was performed for homology search, motif and domain prediction, interacting partners and model validation for drug design. Lead molecule drug properties were checked by Mol Inspiration and OSIRIS property explorer, docking with Vina autodock and phylogenetic analysis of MTHFR with Mega4 against 3 taxa.

 

Key words : Methylene-tetra-hydrofolate reductase, homocysteinuria, In Silico drug.


MAIN

 

FULL-TEXT (SUBSCRIPTION OR PURCHASE TITLE $25USD)